Combining Neprilysin Inhibitor With AT<sub>2</sub>R Agonist Is Superior to Combination With AT<sub>1</sub>R Blocker in Providing Reno-Protection in Obese Rats.

Front Pharmacol · 2021 · PMC8859315 · PMID 35197849

Europe PMC DOI

hedged sentence

0.0538

closest p · 1.1× alpha

0.0538

boldest claim

The sentences

nearly significantp = 0.0538so close (0.05 < p ≤ 0.1)

Only SAC/C21 treatment afforded a nearly significant reduction in cortical renin activity compared to HSD-fed OZR (HSD vs SAC/C21; p = 0.0538) ( Figure 4B ).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.